Clinical Trial: First-in-Human, Multicenter, Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of YL-18319 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumors

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903207) titled 'First-in-Human, Multicenter, Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of YL-18319 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumors' on Sept. 15.

Brief Summary: First-in-Human, multicenter, phase I study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of YL-18319 monotherapy treatment in patients with advanced solid tumors who have progressed or are intolerant to current standard-of-care therapies.

Study Start Date: Oct. 30

Study Type: INTERVENTIONAL

Condition: Solid Tumors Ovarian

Interve...